166 related articles for article (PubMed ID: 26676859)
21. In situ evaluation of spatiotemporal distribution of doxorubicin from Drug-eluting Beads in a tissue mimicking phantom.
Caine M; Bian S; Tang Y; Garcia P; Henman A; Dreher M; Daly D; Carlisle R; Stride E; Willis SL; Lewis AL
Eur J Pharm Sci; 2021 May; 160():105772. PubMed ID: 33621612
[TBL] [Abstract][Full Text] [Related]
22. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
[TBL] [Abstract][Full Text] [Related]
23. Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model.
Rao PP; Pascale F; Seck A; Auperin A; Drouard-Troalen L; Deschamps F; Teriitheau C; Paci A; Denys A; Bize P; de Baere T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1448-59. PubMed ID: 22358992
[TBL] [Abstract][Full Text] [Related]
24. Midterm follow-up after DC-BEAD™-TACE of hepatocellular carcinoma (HCC).
Skowasch M; Schneider J; Otto G; Weinmann A; Woerns MA; Dueber C; Pitton MB
Eur J Radiol; 2012 Dec; 81(12):3857-61. PubMed ID: 22840383
[TBL] [Abstract][Full Text] [Related]
25. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
Aliberti C; Tilli M; Benea G; Fiorentini G
Anticancer Res; 2006; 26(5B):3793-5. PubMed ID: 17094403
[TBL] [Abstract][Full Text] [Related]
26. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.
Taylor RR; Tang Y; Gonzalez MV; Stratford PW; Lewis AL
Eur J Pharm Sci; 2007 Jan; 30(1):7-14. PubMed ID: 17030118
[TBL] [Abstract][Full Text] [Related]
27. Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.
Kilcup N; Tonkopi E; Abraham RJ; Boyd D; Kehoe S
J Biomater Appl; 2015 Jul; 30(1):93-103. PubMed ID: 25690386
[TBL] [Abstract][Full Text] [Related]
28. DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours.
Lewis AL; Holden RR
Expert Opin Drug Deliv; 2011 Feb; 8(2):153-69. PubMed ID: 21222553
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the plasmatic and parenchymal elution kinetics of two different irinotecan-loaded drug-eluting embolics in a pig model.
Gnutzmann DM; Mechel J; Schmitz A; Köhler K; Krone D; Bellemann N; Gockner TL; Mokry T; Kortes N; Sommer CM; Kauczor HU; Radeleff BA; Stampfl U
J Vasc Interv Radiol; 2015 May; 26(5):746-54. PubMed ID: 25704223
[TBL] [Abstract][Full Text] [Related]
30. An in-vitro evaluation of three types of drug-eluting microspheres loaded with irinotecan.
Pereira PL; Plotkin S; Yu R; Sutter A; Wu Y; Sommer CM; Cruise GM
Anticancer Drugs; 2016 Oct; 27(9):873-8. PubMed ID: 27416270
[TBL] [Abstract][Full Text] [Related]
31. A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study.
Duran R; Sharma K; Dreher MR; Ashrafi K; Mirpour S; Lin M; Schernthaner RE; Schlachter TR; Tacher V; Lewis AL; Willis S; den Hartog M; Radaelli A; Negussie AH; Wood BJ; Geschwind JF
Theranostics; 2016; 6(1):28-39. PubMed ID: 26722371
[TBL] [Abstract][Full Text] [Related]
32. Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.
Namur J; Citron SJ; Sellers MT; Dupuis MH; Wassef M; Manfait M; Laurent A
J Hepatol; 2011 Dec; 55(6):1332-8. PubMed ID: 21703190
[TBL] [Abstract][Full Text] [Related]
33. Compatibility of irinotecan-loaded DC Bead with different volumes and types of non-ionic contrast media.
Sarakbi I; Thiesen J; Krämer I
Eur J Hosp Pharm; 2016 Jan; 23(1):38-43. PubMed ID: 31156812
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer.
Keese M; Gasimova L; Schwenke K; Yagublu V; Shang E; Faissner R; Lewis A; Samel S; Löhr M
Int J Cancer; 2009 Jun; 124(11):2701-8. PubMed ID: 19165866
[TBL] [Abstract][Full Text] [Related]
35. Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin.
Baker JH; Lam J; Kyle AH; Sy J; Oliver T; Co SJ; Dragowska WH; Ramsay E; Anantha M; Ruth TJ; Adam MJ; Yung A; Kozlowski P; Minchinton AI; Ng SS; Bally MB; Yapp DT
Clin Cancer Res; 2008 Nov; 14(22):7260-71. PubMed ID: 19010842
[TBL] [Abstract][Full Text] [Related]
36. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.
Martin RC; Howard J; Tomalty D; Robbins K; Padr R; Bosnjakovic PM; Tatum C
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):960-6. PubMed ID: 20661569
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification.
Biondi M; Fusco S; Lewis AL; Netti PA
J Mater Sci Mater Med; 2013 Oct; 24(10):2359-70. PubMed ID: 23797828
[TBL] [Abstract][Full Text] [Related]
38. Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.
Malagari K; Pomoni M; Spyridopoulos TN; Moschouris H; Kelekis A; Dourakis S; Alexopoulou E; Koskinas J; Angelopoulos M; Kornezos J; Pomoni A; Tandeles S; Marinis A; Rizos S; Kelekis D
Cardiovasc Intervent Radiol; 2011 Aug; 34(4):774-85. PubMed ID: 21184228
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K
J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663
[TBL] [Abstract][Full Text] [Related]
40. Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads.
Yagublu V; Caliskan N; Lewis AL; Jesenofsky R; Gasimova L; Löhr JM; Keese M
Pancreatology; 2013; 13(1):79-87. PubMed ID: 23395574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
